Level Four Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Level Four Advisory Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,945	Closed	-$249K	–	786
2023 Q3	$249K	Buy	8,945 +54	+0.6%	+$1.76K	0.02%	624
2023 Q2	$303K	Sell	8,891 -321	-3%	-$10.1K	0.02%	616
2023 Q1	$277K	Buy	+9,212	New	+$285K	0.02%	602
2022 Q2	–	Sell	-5,538	Closed	-$254K	–	561
2022 Q1	$254K	Sell	5,538 -139	-2%	-$6.63K	0.02%	548
2021 Q4	$348K	Buy	+5,677	New	+$392K	0.03%	485
2021 Q3	–	Sell	-46,504	Closed	-$4.3M	–	474
2021 Q2	$4.3M	Buy	46,504 +6,786	+17%	+$577K	0.3%	78
2021 Q1	$3.52M	Buy	+39,718	New	+$3.94M	0.27%	96

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Main Management San Francisco, California $1.37B AUM 19.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Level Four Advisory Services's ARKG Position: Q4 2023 in Review

Level Four Advisory Services sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 8,945 shares — an estimated $249K sold.

Level Four Advisory Services first reported a position in ARKG in Q1 2021 and held it in 7 quarters. The position peaked at $4.3M in Q2 2021. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

Level Four Advisory Services reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
Level Four Advisory Services sold 8,945 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $249K.
Level Four Advisory Services first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 7 quarters.
Level Four Advisory Services's ARK Genomic Revolution ETF position peaked at $4.3M in Q2 2021.
298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Level Four Advisory Services's 13F filing for Q4 2023, filed 8 Feb 2024.